Ketamine use in relation to depressive symptoms among high school seniors

Background and Objectives Ketamine is efficacious in treating treatment‐resistant depression in medical settings and the drug was approved for such use by the US Federal Drug Administration in 2019. However, little is known about how use outside of medical settings relates to depression. We determin...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The American journal on addictions 2022-03, Vol.31 (2), p.100-107
Hauptverfasser:	Palamar, Joseph J., Kumar, Sakthi, Yang, Kevin H., Han, Benjamin H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Depression - drug therapy Depression - epidemiology Humans Ketamine - adverse effects Prevalence Schools Substance-Related Disorders - drug therapy Substance-Related Disorders - epidemiology United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!